![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Keam Susan J.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.67, Iss.13, 2007-01, pp. : 1917-1929
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Telbivudine for the treatment of hepatitis B disease
By Tsunoda Shirley M Hassanein Tarek
Future Virology, Vol. 3, Iss. 6, 2008-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Telbivudine triumphs over opponents in hepatitis B
Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Telbivudine making a global impact on hepatitis B
Inpharma, Vol. 1, Iss. 1525, 2006-01 ,pp. :